Biggest News Aggregation in the World
📰 Hookipa Pharma News

Page 3 - Hookipa Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hookipa Pharma. Real-time updates on events, politics, business and more.

Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Declines By 11.5%

Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 805,900 shares, a decline of 11.5% from the June 30th total of 910,600 shares. Currently, 1.2% of the company’s stock are short sold. […]
Hookipa Pharma Vanguard Group Inc Jefferies Financial Group Inc Alyeska Investment Group Royal Bank Acadian Asset Management
Source: wkrb13.com

Insider Buying: Hookipa Pharma Inc (NASDAQ:HOOK) CFO Acquires $10,560.00 in Stock

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera purchased 12,000 shares of Hookipa Pharma stock in a transaction that occurred on Friday, June 30th. The stock was purchased at an average price of $0.88 per share, with a total value of $10,560.00. Following the transaction, the chief financial officer now owns 28,092 shares […]
Hookipa Pharma Reinhard Kandera Susquehanna International Group Pharma Inc Hookipa Pharma Inc Mirabella Financial Services

Reinhard Kandera Purchases 12,000 Shares of Hookipa Pharma Inc (NASDAQ:HOOK) Stock

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera acquired 12,000 shares of Hookipa Pharma stock in a transaction on Friday, June 30th. The stock was purchased at an average cost of $0.88 per share, for a total transaction of $10,560.00. Following the purchase, the chief financial officer now owns 28,092 shares in the […]
Hookipa Pharma Reinhard Kandera Alyeska Investment Group Hookipa Pharma Inc Acadian Asset Management Millennium Management

Hookipa Pharma Inc (NASDAQ:HOOK) CFO Acquires $10,560.00 in Stock

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera acquired 12,000 shares of the company’s stock in a transaction on Friday, June 30th. The stock was acquired at an average cost of $0.88 per share, with a total value of $10,560.00. Following the completion of the purchase, the chief financial officer now directly owns […]
United States Reinhard Kandera Hookipa Pharma America Corp Hookipa Pharma Inc Hookipa Pharma Company Profile

Hookipa Pharma Inc (NASDAQ:HOOK) Sees Large Increase in Short Interest

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 721,000 shares, an increase of 951.0% from the May 31st total of 68,600 shares. Approximately 1.1% of the shares of the company are short sold. Based on […]
Hookipa Pharma Mirabella Financial Services Susquehanna International Group Virtu Financial Pharma Inc Hookipa Pharma Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Global Cancer Vaccine Partnering Terms and Agreements Analysis Report/Directory 2023: Access Over 350 Cancer Vaccine Deals - Disclosed Headlines, Upfronts, Milestones and Royalties

/PRNewswire/ -- The "Global Cancer Vaccine Partnering Terms and Agreements 2010-2023" report has been added to ResearchAndMarkets.coms offering. The Global...
United States Dainippon Sumitomo Pharma Laura Wood Selecta Biosciences Daiichi Sankyo Hookipa Pharma

Comparing Hookipa Pharma (NASDAQ:HOOK) & Apollomics (NASDAQ:APLM)

Hookipa Pharma (NASDAQ:HOOK – Get Rating) and Apollomics (NASDAQ:APLM – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Volatility & Risk Hookipa Pharma has a beta of 0.83, […]
New York United States Foster City Hookipa Pharma Gilead Sciences Inc Pharmaceuticals Inc

Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update

Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 68,600 shares, a drop of 78.2% from the May 15th total of 314,900 shares. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is […]
United States Hookipa Pharma Virtu Financial Pharma Inc America Corp Susquehanna International Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science